Table 2 ER association of the 22 individual 3D signature genes in three patient datasets (Welch t-test p values with false positive multigene correction).

Table S1. List of 22 genes in prognostic signature of Fournier et al. 2006

Table W1. List of Genes Up-regulated in Short-term Survivors; 77 probe sets identified with greater than threefold expression in short than in long-term survivors (q < 15%). Two of these probe sets encode clusterin that was up-regulated 3.8-fold more in short- than in long-term survivors

Table S1 List of the 86 Affymetrix probe sets contained in the prognostic gene signature

Supplementary Table 2c. Genes differentially expressed in Group A and Group B chronic myeloid leukaemia (CML) samples; Genes involved in adhesion

SuppTable2g Genes related to signal transduction

SuppTable2h Genes involved in protein phosporilation

SuppTable2d Genes related to ubiquitination

SuppTable2e Genes related to union/transport of proteins or molecules

SuppTable2a Genes involved in proliferation/apoptosis

SuppTable2m Genes related to the ubiquitination process

Supplementary Table 2f. Genes differentially expressed in Group A and Group B chronic myeloid leukaemia (CML) samples;  Genes involved in metabolism

SuppTable2o Genes involved in protein phosphorilation

SuppTable2b Genes involved in transcription

SuppTable2k Genes related to cell adhesion

SuppTable2q Genes involved in protein translation

SuppTable2i Genes involved in proliferation/apoptosis

SuppTable2n Genes related to union/transport of proteins or molecules

SuppTable2r Genes with a mostly unknown biologic function

SuppTable2l Genes involved in signal transduction

Supplementary Table 2p. Genes differentially expressed in Normal bone marrow (BM) samples and complete cytogenetic response (CCyR) chronic myeloid leukaemia (CML) samples; Genes involved in metabolism

SuppTable2j Genes related to transcription

Table 2. Top differentially expressed transcripts in hereditary inclusion body myopathy (HIBM); the 35 genes with the highest fold difference in expression between healthy and HIBM muscle tissue